Listing 1 - 2 of 2 |
Sort by
|
Choose an application
[Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis—an imbalance in the composition and organization of microbial populations—could severely impact the development of different medical conditions (from metabolic to mood disorders), providing new insights into the comprehension of diverse diseases, such as IBD, obesity, asthma, autism, stroke, diabetes, and cancer. Given that microbial cells in the gut outnumber host cells, microbiota influences human physiology both functionally and structurally. Microbial metabolites bridge various—even distant—areas of the organism by way of the immune and hormone system. For instance, it is now clear that the mutual interaction between the gastrointestinal tract and the brain (gut–brain axis), often involves gut microbiota, indicating that the crosstalk between the organism and its microbial residents represents a fundamental aspect of both the establishment and maintenance of healthy conditions. Moreover, it is crucial to recognize that beyond the intestinal tract, microbiota populates other host organs and tissues (e.g., skin and oral mucosa). We have edited this eBook with the aim of publishing manuscripts focusing on the impact of microbiota in the development of different diseases and their associated treatments.]
gastrointestinal diseases --- sterile inflammation --- n/a --- Staphylococcus spp. --- etiopathogenesis --- colitis --- Escherichia coli --- bacteriophages --- atopic dermatitis --- intravenous immunoglobulin G --- adaptive immunity --- 16S rRNA gene --- vaginal microbiota --- modularity --- innate immunity --- gut-liver axis --- disease activity --- immune system --- cytokines --- commensals --- Staphylococcus aureus --- dysbiosis --- fecal transplantation --- TLR mimicry --- etanercept --- dextran sulfate sodium --- CAR T-cell --- 3-dihydroxy-4-methoxyBenzaldehyde --- chemo free treatment --- Staphylococcus epidermis --- rheumatoid arthritis --- microbiome --- co-occurrence network --- immune epigenetics --- 2 --- autoimmunity --- superoxide dismutase --- precision medicine --- metabolism --- adoptive cell transfer (ACT) --- gut barrier --- antibiotics --- checkpoint inhibitors --- probiotics --- microbiota --- Candida albicans --- Enterococcus faecalis --- chronic liver diseases --- TCR --- anaerobic bacteria --- HSV2 --- bacteriocins --- methotrexate --- microbial interactions --- T cells --- virus --- mice --- lymphoid malignancies --- HPV --- macrophages --- anti-TNF-? --- inflammation --- chondroitin sulfate disaccharide --- immunotherapy --- genomics --- immuno-oncology --- diet --- aerobic bacteria --- immunological niche --- melanin --- health --- chemokines --- gut microbiota --- cutaneous immunity --- HIV --- TIL --- cancer --- global network
Choose an application
Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.
receptor activator of nuclear factor ?B --- infliximab --- tripterine --- triptolide --- osteoblast --- tumor necrosis factor-alpha --- synovial cell --- anti-arthritis --- biosimilars --- Epstein-Barr virus --- cytokines --- SOX9 --- parathyroid hormone --- nitric oxide --- rat --- etanercept --- angiogenesis --- glycosylation --- mitogen activated protein kinase --- Th9 lymphocytes --- rheumatoid arthritis --- IL-6 --- clodronate --- bone erosion --- mesenchymal stem cells --- collagen-induced arthritis --- biological --- gene expression --- inflammatory arthritis --- osteoarthritis --- fraxinellone --- nuclear factor kappa B --- messenger RNA --- inflammation --- miRNA --- disease-modifying --- adipokines --- WNT --- glycoprotein 42 --- miR-199a-5p --- proliferation --- next-generation sequencing --- collagen --- osteoarthritis (OA) --- experimental arthritis --- bone morphogenetic protein --- TNF-? --- computational modeling --- basic research --- osteoclast --- therapeutics --- certolizumab pegol --- chondrocytes --- progenitor cells --- adjuvant arthritis --- adalimumab --- triterpenoid --- sclareol --- TNF? --- fibroblast growth factor 2 --- antibodies --- osteoblasts --- molecular pathology --- Th17 --- immunology --- obesity --- visfatin --- articular cartilage --- autoimmune --- biomarkers --- celastrol --- MAPK --- disease pathways --- IL1? --- arthritis --- bioinformatics --- anticitrullinated peptide antibodies --- drug delivery system --- antagonists --- shared epitope --- pathology --- SMA- and MAD-related protein --- small-molecule inhibitor --- transforming growth factor ? --- mice --- golimumab --- spinal fusion --- antirheumatic drug --- early osteoarthritis --- stem cell --- rheumatoid factor --- therapeutic antibody --- bisphosphonate --- osteoclastogenesis --- interleukin --- spondyloarthropathies --- clinical translation --- therapy --- Traditional Chinese medicine --- chemokines --- structure --- cell signaling --- microRNA
Listing 1 - 2 of 2 |
Sort by
|